6.70 0.00 (0.00%)
After hours: 5:06PM EDT
| Previous Close | 6.70 |
| Open | 6.66 |
| Bid | 6.75 x 900 |
| Ask | 6.75 x 900 |
| Day's Range | 6.66 - 6.83 |
| 52 Week Range | 3.05 - 20.00 |
| Volume | 145,074 |
| Avg. Volume | 502,259 |
| Market Cap | 226.183M |
| Beta (3Y Monthly) | 2.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.05 (0.68%) |
| Ex-Dividend Date | 2019-07-03 |
| 1y Target Est | N/A |
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares payable July 22, 2019 to shareholders of record on July 5, 2019.
NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Invacare Corp. (NYSE: IVC ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 8:30 AM Eastern Time. To ...
Operational initiatives deliver improvement in SG&A and free cash flow
Invacare Corporation announces that it will release its financial results for the first quarter ended March 31, 2019, after the market closes on Monday, May 6, 2019.
Matthew E. Monaghan, chairman, president and chief executive officer of Invacare Corporation , will present at the 18th Annual Needham Healthcare Conference at the Westin NY Grand Central Hotel in New York on Tuesday, April 9, 2019.
Matthew E. Monaghan, chairman, president and chief executive officer and Kathleen P. Leneghan, senior vice president and chief financial officer of Invacare Corporation , will participate in the 2019 Morgan Stanley Healthcare Corporate Access Day at the Boston Harbor Hotel in Boston, MA on Tuesday, March 19, 2019.
NEW YORK, Feb. 20, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
HENDERSON, NV / ACCESSWIRE / February 15, 2019 / Pain relief medicines are a massive market 30 billion doses of which are consumed each year in the US alone. Opioids like codeine and hydrocodone are also ...
Provides Update on Enhanced Transformation and Growth Plan, Introduces Full Year 2019 Guidance
Provides Update on Transformation Plan
NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Invacare Corporation today reported results for the quarter ended September 30, 2018.
Matthew E. Monaghan, chairman, president and chief executive officer of Invacare Corporation , will present at the 2018 Stephens NY Investment Conference at the Lotte New York Palace Hotel in New York on Thursday, November 8, 2018.
Invacare Corporation announces that it will release its financial results for the third quarter ended September 30, 2018, after the market closes on Monday, November 5, 2018.
Invacare Corporation (IVC) today announced its conference schedule for September 2018. On Wednesday, September 12, at 5:25 p.m. ET, Matthew E. Monaghan, chairman, president and chief executive officer will present at the Morgan Stanley 2018 Global Healthcare Conference at the Grand Hyatt in New York. The live webcast of the presentation will be available at https://cc.talkpoint.com/morg007/091218a_as/?entity=29_68B6B6D and it will be accessible for replay for 90 days following the conference.
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Invacare Corporation (NYSE: IVC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:30:00 AM Eastern Time. ...
Invacare Corporation today reported results for the quarter ended June 30, 2018.
Invacare Corporation announces that it will release its financial results for the second quarter ended June 30, 2018, after the market closes on Tuesday, August 7, 2018.
Matthew E. Monaghan, chairman, president and chief executive officer and Kathy Leneghan, senior vice president and chief financial officer of Invacare Corporation , will participate in the 3rd Annual Needham MedTech 1x1 Conference in Boston on Tuesday, August 7, 2018.
Invacare Corporation (IVC) today announced the appointment of Diana S. Ferguson, to its Board of Directors, effective July 19, 2018. Ms. Ferguson currently serves as Chief Financial Officer for Cleveland Avenue, LLC, a privately-held venture capital firm which accelerates and strategically invests in innovative restaurant, food and beverage concepts and emerging brands. In addition, since August 2013, Ms. Ferguson has served as Principal of Scarlett Investments, LLC, a firm that invests in and advises middle market businesses.